(1R,2R,3S,5S)-3-(苯甲酰氧基)-2-(甲酯基<甲氧羰基>)-8,8-二甲基-8-氮鎓杂二环[3.2.1]辛烷碘化 | 5587-76-8

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 中文名称: (1R,2R,3S,5S)-3-(苯甲酰氧基)-2-(甲酯基&lt甲氧羰基&gt)-8,8-二甲基-8-氮鎓杂二环[3.2.1]辛烷碘化
• 英文名称: Sodium cyclopent-2-ene-1-undecanoate
• 英文别名: sodium;11-cyclopent-2-en-1-ylundecanoate
• CAS: 5587-76-8
• 化学式: C16H27NaO2
• 分子量: 274.37
• InChiKey: PCZFVTPRFQOIND-UHFFFAOYSA-M

计算性质

• 辛醇/水分配系数(LogP)：
  0.61
• 重原子数：
  19
• 可旋转键数：
  10
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.81
• 拓扑面积：
  40.1
• 氢给体数：
  0
• 氢受体数：
  2

文献信息

• COMPOSITIONS AND METHODS COMPRISING PANAX SPECIES
  申请人：Herbalscience Singapore Pte. Ltd.

  公开号：EP1937289A2

  公开（公告）日：2008-07-02
• EP1937289A4
  申请人：——

  公开号：EP1937289A4

  公开（公告）日：2009-07-29
• Methods and compositions comprising Panax species
  申请人：Gow T. Robert

  公开号：US20070065526A1

  公开（公告）日：2007-03-22

  The present invention comprises compositions comprising essential oils, ginsenosides, and polysaccharides. The present invention comprises methods comprising sequential solvent extraction and polymer absorbent purification to obtain fractions comprising essential oils, ginsenosides, and polysaccharides. The compositions of the present invention may be used in forms such as tablets, gel caps, or fast-dissolve tablets for use as dietary supplements or pharmaceutical compositions. The compositions of the present invention may be used for treatment of cardiovascular diseases, neurodegenerative diseases, inflammatory diseases, hepatic disorders, viral diseases, and cancer.
• US7790905B2
  申请人：——

  公开号：US7790905B2

  公开（公告）日：2010-09-07
• US7927613B2
  申请人：——

  公开号：US7927613B2

  公开（公告）日：2011-04-19